ALPAPharmaceuticals
Alpa Laboratories Ltd — Balance Sheet
₹46.46
-9.93%
Alpa Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.10 Cr | 2.10 Cr | 2.10 Cr | 2.10 Cr | — |
| Share Issued | 2.10 Cr | 2.10 Cr | 2.10 Cr | 2.10 Cr | — |
| Total Debt | 0.00 | 5.25 Cr | 2.30 Cr | 5.85 Cr | — |
| Tangible Book Value | 171.39 Cr | 151.85 Cr | 134.49 Cr | 121.63 Cr | — |
| Invested Capital | 171.43 Cr | 157.16 Cr | 136.88 Cr | 127.58 Cr | — |
| Working Capital | 144.51 Cr | 132.67 Cr | 116.65 Cr | 106.63 Cr | — |
| Net Tangible Assets | 171.39 Cr | 151.85 Cr | 134.49 Cr | 121.63 Cr | — |
| Common Stock Equity | 171.43 Cr | 151.91 Cr | 134.58 Cr | 121.73 Cr | — |
| Total Capitalization | 171.43 Cr | 151.91 Cr | 135.35 Cr | 123.86 Cr | — |
| Total Equity Gross Minority Interest | 171.43 Cr | 151.91 Cr | 134.58 Cr | 121.73 Cr | — |
| Stockholders Equity | 171.43 Cr | 151.91 Cr | 134.58 Cr | 121.73 Cr | — |
| Other Equity Interest | 150.39 Cr | 130.87 Cr | 113.54 Cr | 100.69 Cr | — |
| Capital Stock | 21.04 Cr | 21.04 Cr | 21.04 Cr | 21.04 Cr | — |
| Common Stock | 21.04 Cr | 21.04 Cr | 21.04 Cr | 21.04 Cr | — |
| Total Liabilities Net Minority Interest | 51.16 Cr | 30.46 Cr | 32.69 Cr | 33.51 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 4.49 Cr | 2.40 Cr | 3.06 Cr | 2.12 Cr | — |
| Non Current Deferred Taxes Liabilities | 4.49 Cr | 2.40 Cr | 2.28 Cr | 2.57 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.78 Cr | 2.12 Cr | — |
| Long Term Debt | 0.00 | 0.00 | 0.78 Cr | 2.12 Cr | — |
| Current Liabilities | 46.67 Cr | 28.07 Cr | 29.63 Cr | 31.38 Cr | — |
| Other Current Liabilities | 21.36 Cr | 7.83 Cr | 2.28 Cr | 2.57 Cr | — |
| Current Provisions | 5.56 Cr | 2.11 Cr | 3.68 Cr | 2.65 Cr | — |
| Payables | 18.69 Cr | 13.78 Cr | 15.94 Cr | 15.90 Cr | — |
| Accounts Payable | 18.69 Cr | 11.78 Cr | 15.06 Cr | 14.92 Cr | — |
| Total Assets | 222.59 Cr | 182.37 Cr | 167.27 Cr | 155.24 Cr | — |
| Total Non Current Assets | 31.41 Cr | 21.39 Cr | 17.39 Cr | 17.23 Cr | — |
| Investmentin Financial Assets | 10.76 Cr | 1.40 Cr | 1.34 Cr | 1.54 Cr | — |
| Available For Sale Securities | 10.76 Cr | 1.40 Cr | 1.34 Cr | 1.54 Cr | — |
| Long Term Equity Investment | 0.00 | 6.87 Cr | 5.68 Cr | 5.93 Cr | — |
| Goodwill And Other Intangible Assets | 0.05 Cr | 0.06 Cr | 0.08 Cr | 0.10 Cr | — |
| Net PPE | 20.60 Cr | 11.41 Cr | 6.96 Cr | 9.22 Cr | — |
| Gross PPE | 20.60 Cr | 39.72 Cr | 33.33 Cr | 34.28 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other Properties | 20.60 Cr | 5.86 Cr | 5.83 Cr | 5.82 Cr | — |
| Current Assets | 191.18 Cr | 160.74 Cr | 146.29 Cr | 138.01 Cr | — |
| Other Current Assets | 8.92 Cr | 0.07 Cr | 8.16 Cr | 7.27 Cr | — |
| Inventory | 17.64 Cr | 13.67 Cr | 12.64 Cr | 15.46 Cr | — |
| Other Receivables | 0.54 Cr | 1.61 Cr | 1.74 Cr | 6.25 Cr | — |
| Taxes Receivable | 3.32 Cr | 1.94 Cr | 0.15 Cr | 0.19 Cr | — |
| Accounts Receivable | 46.83 Cr | 41.15 Cr | 46.73 Cr | 38.04 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 113.94 Cr | 92.85 Cr | 80.84 Cr | 70.27 Cr | — |
| Other Short Term Investments | 113.91 Cr | 91.14 Cr | 72.03 Cr | 68.70 Cr | — |
| Cash And Cash Equivalents | 0.03 Cr | 1.71 Cr | 8.81 Cr | 1.58 Cr | — |
| Net Debt | — | 3.54 Cr | — | 4.27 Cr | — |
| Work In Process | — | 2.75 Cr | 0.88 Cr | 0.90 Cr | 2.70 Cr |
| Retained Earnings | — | 75.91 Cr | 58.58 Cr | 45.73 Cr | 31.64 Cr |
| Additional Paid In Capital | — | 54.96 Cr | 54.96 Cr | 54.96 Cr | 54.96 Cr |
| Other Non Current Liabilities | — | -1000.00 | 1000.00 | -2000.00 | 1000.00 |
| Current Debt And Capital Lease Obligation | — | 5.25 Cr | 1.53 Cr | 3.72 Cr | 0.18 Cr |
| Current Debt | — | 5.25 Cr | 1.53 Cr | 3.72 Cr | 0.18 Cr |
| Other Payable | — | 2.01 Cr | 0.88 Cr | 0.98 Cr | 1.05 Cr |
| Total Tax Payable | — | 0.00 | 0.00 | 0.00 | 0.28 Cr |
| Non Current Prepaid Assets | — | 0.52 Cr | 1.45 Cr | 0.22 Cr | 0.23 Cr |
| Investments In Other Ventures Under Equity Method | — | 6.87 Cr | 5.68 Cr | 5.93 Cr | 10.15 Cr |
| Other Intangible Assets | — | 0.06 Cr | 0.08 Cr | 0.10 Cr | 0.06 Cr |
| Accumulated Depreciation | — | -28.31 Cr | -26.38 Cr | -25.07 Cr | -23.42 Cr |
| Machinery Furniture Equipment | — | 27.19 Cr | 22.34 Cr | 23.30 Cr | 19.60 Cr |
| Buildings And Improvements | — | 6.54 Cr | 5.03 Cr | 5.03 Cr | 5.03 Cr |
| Land And Improvements | — | 0.13 Cr | 0.13 Cr | 0.13 Cr | 0.13 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 9.45 Cr | 4.17 Cr | 7.80 Cr | 13.99 Cr |
| Finished Goods | — | 2.50 Cr | 3.73 Cr | 4.98 Cr | 3.71 Cr |
| Raw Materials | — | 8.42 Cr | 8.03 Cr | 9.59 Cr | 10.15 Cr |
| Cash Financial | — | 1.71 Cr | 8.81 Cr | 1.58 Cr | 1.80 Cr |
| Current Deferred Taxes Liabilities | — | — | 2.28 Cr | 2.57 Cr | 0.22 Cr |
| Goodwill | — | — | — | 0.10 Cr | 0.06 Cr |
| Restricted Cash | — | — | — | 0.93 Cr | 8.71 Cr |
| Gross Accounts Receivable | — | — | — | 38.04 Cr | 35.43 Cr |
| Non Current Deferred Taxes Assets | — | — | — | — | 0.00 |
| Other Inventories | — | — | — | — | 1000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Alpa Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.